37 Treatment Choice: More than Efficacy Treatment decisions should take into account patient preference, and patient and tumour characteristics 1L treatment Expectations Toxicity profile Flexibility Socioeconomic factors Quality of life Expectations Toxicity profile Flexibility Socioeconomic factors Quality of life Age Performance status Prior adjuvant treatment Comorbidities Age Performance status Prior adjuvant treatment Comorbidities Tumour characteristics Patient preference Patient characteristics Clinical presentation Tumour biology RAS mutation status BRAF mutation status Clinical presentation Tumour biology RAS mutation status BRAF mutation status
{}